Novel Recombinant Streptococcus mitis as an Oral Vaccine against HIV/AIDS

Project: Research project

Project Details

Description

HIV/AIDS is a major global public health problem that needs an immediate solution. We propose to develop an innovative and novel recombinant Streptococcus mitis vaccine technology that will protect against HIV infection.
StatusFinished
Effective start/end date7/1/176/30/22

Funding

  • National Institute of Dental and Craniofacial Research: $475,721.00
  • National Institute of Dental and Craniofacial Research: $509,279.00
  • National Institute of Dental and Craniofacial Research: $718,151.00
  • National Institute of Dental and Craniofacial Research: $470,578.00

ASJC Scopus Subject Areas

  • Immunology
  • Infectious Diseases

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.